PATHSENSORS
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Series A | ||
$1.8m | Convertible | ||
N/A | $169k | Debt | |
$500k | Seed | ||
N/A | Acquisition | ||
Total Funding | €2.1m |
Recent News about PATHSENSORS
EditPathSensors, Inc. is a biotechnology company specializing in advanced pathogen detection systems. Utilizing technology exclusively licensed from the MIT Lincoln Laboratory, PathSensors has developed three core platforms: BioFlash, Zephyr, and Navigator. These platforms are designed to detect a wide range of deadly pathogens, helping to prevent outbreaks before they spread. The company serves various industries, including public health, agriculture, and security, by providing rapid and accurate detection solutions. PathSensors operates in the biotechnology market and generates revenue through the sale of its detection systems and related services. The business model focuses on continuous innovation and expanding its library of threat detection capabilities to meet emerging and specific requirements.
Keywords: pathogen detection, biotechnology, BioFlash, Zephyr, Navigator, outbreak prevention, public health, agriculture, security, MIT Lincoln Laboratory.